Low-intensity shockwave therapy (LISWT) has recently emerged as a promising method in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors in the treatment of erectile dysfunction (ED). Erectile dysfunction (ED) is a medical entity that is highly prevalent in men older than 50 years whose history of vascular risk factors (VRFs) has been a common denominator in the origin of this symptom. It is very common in India too.
India is the Impotence capital of the world about 50percent people above 40 yrs suffer it. Many studies have stressed the status of ED as a potential indicator of cardiovascular disease, although other clinical trials have found a high incidence of ED in men with VRFs such as metabolic syndrome, diabetes, and hypertension. Since 1998, the phosphodiesterase type 5 inhibitor (PDE5i) has introduced a change in the treatment paradigm for patients with ED because…
